Amgen Inc

Exclusive news, data and analytics for financial market professionalsLearn more about

Skip to main content

Company

Amgen Inc

109 results

DisruptedcategoryNvidia turns to AI cloud rental to spread new technology, article with galleryMarch 21, 2023
BusinesscategoryAmgen to cut 450 jobs in second round of layoffs this year, article with imageMarch 17, 2023
LegalcategoryAmgen is sued for concealing $10.7 billion tax bill from investors, article with imageMarch 14, 2023
Future of HealthcategoryUS FDA approves Pfizer's nasal spray for migraine, article with imageMarch 10, 2023
BusinesscategoryDrug developer QurAlis raises $88 mln in Sanofi-backed funding roundMarch 9, 2023
Future of HealthcategoryMerck's drug boosts exercise capacity in pulmonary hypertension patients, article with imageMarch 6, 2023
BreakingviewscategoryInsulin cuts make drug prices a little less bazaar, article with imageMarch 1, 2023
Healthcare & PharmaceuticalscategoryU.S. FDA declines to approve Cytokinetics' heart drug, article with imageMarch 1, 2023
MarketscategoryUS companies rush to issue corporate debt, busiest February ever, article with imageFebruary 28, 2023
MarketscategorySoros Fund adds First Horizon, Horizon Therapeutics and bond ETF, article with imageFebruary 14, 2023
BusinesscategoryAbbVie sees 37% drop in Humira sales this year as biosimilars hit U.S. market, article with imageFebruary 9, 2023
BusinesscategoryCigna expects revenue gains from launches of Humira biosimilars, article with galleryFebruary 3, 2023
MarketscategoryWall St rallies as Fed's Powell nods to easing inflation after rate hike, article with videoFebruary 2, 2023
Future of HealthcategoryAbbVie's Humira gets a U.S. rival, but costs could stay high, article with galleryFebruary 1, 2023
BusinesscategoryAmgen revenue falls slightly as Lilly COVID deal contributes less, article with imageJanuary 31, 2023
BusinesscategoryAmgen launches biosimilar version of AbbVie's Humira, article with galleryJanuary 31, 2023
MarketscategoryMorning Bid: 'Soft landing' or 'no landing'?, article with imageJanuary 31, 2023
World at WorkcategoryDrugmaker Amgen lays off 300 U.S. employees, article with imageJanuary 30, 2023
MarketscategoryU.S. Senator Warren 'particularly concerned' about Amgen, Indivior deals, article with imageJanuary 26, 2023
FOCUSDrug companies favor biotech meds over pills, citing new U.S. law, article with galleryJanuary 13, 2023

1 to 20 of 109